Stock SCPX SCORPIUS HOLDINGS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Scorpius Holdings, Inc.

Equities

SCPX

US42237K4094

Market Closed - Nyse
Other stock markets
 04:10:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
0.169 USD +3.49% Intraday chart for Scorpius Holdings, Inc. +7.64% -61.62%
Apr. 26 Scorpius Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Apr. 23 Scorpius Holdings Gets Non-Compliance Notice From NYSE American MT

Evolution of the average Target Price on Scorpius Holdings, Inc.

Price target over the last 5 years

History of analyst recommendation changes

e76481efc9ef9cf0aa838.dCjHkwE4R0mltyEkzdbUkFsY0kC_IkBjlHQu1MUTnXo.PmGj-zBtMmT81Hhc4OOR8zN2sA_8agoTpAZDl6lW6TknXo7-UkoLM_DhVg~c540615f08a65595569a758250aff3a5

Analyst Recommendations on Scorpius Holdings, Inc.

Brookline Capital Downgrades NightHawk Biosciences to Hold From Buy MT
Maxim Downgrades NightHawk Biosciences to Hold From Buy MT
B. Riley Lowers Heat Biologics' PT to $8 from $10, Adjusts Model for Higher Cost of Capital to Support Higher Operating Expenditures Ramp; Keeps Buy Rating MT
Alliance Global Adjusts Heat Biologics' Price Target to $15.50 From $20, Reiterates Buy Rating MT
B. Riley Lowers Heat Biologics' Price Target to $10 from $15 After Revising Cost Capital Assumptions, Keeps Buy Rating MT
HEAT BIOLOGICS : Alliance Global Adjusts Price Target on Heat Biologics to $20 From $32, Reiterates Buy Rating MT
HEAT BIOLOGICS : B. Riley Lowers Heat Biologics' PT to $15 from $20 to Reflect Increased Research and Development Investment, Keeps Buy Rating MT
HEAT BIOLOGICS : Cantor Fitzgerald Starts Heat Biologics at Overweight With $22 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
0.169 USD
Average target price
10 USD
Spread / Average Target
+5,817.16%
High Price Target
10 USD
Spread / Highest target
+5,817.16%
Low Price Target
10 USD
Spread / Lowest Target
+5,817.16%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Scorpius Holdings, Inc.

Brookline Capital Markets
Maxim
B. Riley
Alliance Global Partners
Cantor Fitzgerald

Ratings for Scorpius Holdings, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. SCPX Stock
  4. Consensus Scorpius Holdings, Inc.